<http://webisa.webdatacommons.org/prov/137573520>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/345970698> .
<http://webisa.webdatacommons.org/prov/481875054>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/345970698> .
<http://webisa.webdatacommons.org/345970698>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/345970698>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<sec.gov> .
<http://webisa.webdatacommons.org/345970698>	<http://www.w3.org/ns/prov#value>	"to biologics under the PHS Act, or devices or drugs under the FDCA, including premarket licensure, clearance or approval." .